Search

Your search keyword '"Ippazio Cosimo Antonazzo"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Ippazio Cosimo Antonazzo" Remove constraint Author: "Ippazio Cosimo Antonazzo"
67 results on '"Ippazio Cosimo Antonazzo"'

Search Results

1. Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy

2. A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy

3. Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression

4. Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy

5. Azithromycin use and outcomes in patients with COVID-19: an observational real-world study

6. Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients

7. The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study

8. Time trends in the incidence of essential tremor: Evidences from UK and France primary care data

9. The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis

10. Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy

11. Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study

12. Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

13. Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region

14. Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis

15. Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice

16. Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres.

17. Raphanus sativus cv. Sango Sprout Juice Decreases Diet-Induced Obesity in Sprague Dawley Rats and Ameliorates Related Disorders.

18. Abstract P6-08-01: A cost-consequence analysis of pertuzumab in the neoadjuvant treatment of high-risk HER2+ Early-Stage Breast Cancer (EBC): health-economic considerations for drug availability in Italy

19. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up

20. Long-term refracture and mortality assessment in fractured elderly individuals: an evidence-based analysis based on T.A.R.Ge.T data

21. Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women

22. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019

23. Haemophilia management and treatment: An Italian survey on patients', caregivers' and clinicians' point of view

24. Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system

25. Impact of COVID-19 Lockdown, during the Two Waves, on Drug Use and Emergency Department Access in People with Epilepsy: An Interrupted Time-Series Analysis

26. Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018

27. Global, regional, and national burden of stroke and its risk factors, 1990–2019 : a systematic analysis for the Global Burden of Disease Study 2019

28. Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study

29. Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy

30. Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research

31. Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system

32. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System

33. Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems

34. Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months

35. COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases

36. Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy

37. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study

38. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

39. Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System

40. Post-stroke epilepsy and mortality: an observational study on healthcare administrative database

41. 5PSQ-101 Drug–drug interactions and potentially related adverse clinical events in patients with cardiovascular diseases

42. Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting

43. PCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world Study

44. Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System

45. Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?

46. Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety

47. Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study

48. Drug-induced Kounis syndrome: A matter of pharmacovigilance

49. Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres

50. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis

Catalog

Books, media, physical & digital resources